Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 137

1.

[Erratum to: "Immunotherapy and allogeneic stem cells transplantation" [Bull. Cancer 103 (2016) S164-174]].

Fontbrune FS, Cavalieri D, Leclerc M, Beckerich F, Maury S, Latour RP, N-Guyen S, Bay JO.

Bull Cancer. 2017 Apr 1. pii: S0007-4551(17)30063-2. doi: 10.1016/j.bulcan.2017.02.006. [Epub ahead of print] French. No abstract available.

PMID:
28372793
2.

Intragenic FMR1 disease-causing variants: a significant mutational mechanism leading to Fragile-X syndrome.

Quartier A, Poquet H, Gilbert-Dussardier B, Rossi M, Casteleyn AS, Portes VD, Feger C, Nourisson E, Kuentz P, Redin C, Thevenon J, Mosca-Boidron AL, Callier P, Muller J, Lesca G, Huet F, Geoffroy V, El Chehadeh S, Jung M, Trojak B, Le Gras S, Lehalle D, Jost B, Maury S, Masurel A, Edery P, Thauvin-Robinet C, Gérard B, Mandel JL, Faivre L, Piton A.

Eur J Hum Genet. 2017 Apr;25(4):423-431. doi: 10.1038/ejhg.2016.204. Epub 2017 Feb 8.

PMID:
28176767
3.

Hyper-CVAD + epratuzumab as salvage regimen for younger patients with relapsed/refractory CD22+ precursor B-cell ALL.

Chevallier P, Chantepie S, Huguet F, Raffoux E, Thomas X, Leguay T, Marchand T, Isnard F, Charbonnier A, Maury S, Gallego-Hernanz MP, Robillard N, Guillaume T, Peterlin P, Garnier A, Rialland F, Le Houerou C, Goldenberg DM, Wegener WA, Béné MC, Dombret H; GRAALL..

Haematologica. 2017 Feb 2. pii: haematol.2016.159905. doi: 10.3324/haematol.2016.159905. [Epub ahead of print]

4.

Folivory elicits a strong defense reaction in Catharanthus roseus: metabolomic and transcriptomic analyses reveal distinct local and systemic responses.

Dugé de Bernonville T, Carqueijeiro I, Lanoue A, Lafontaine F, Sánchez Bel P, Liesecke F, Musset K, Oudin A, Glévarec G, Pichon O, Besseau S, Clastre M, St-Pierre B, Flors V, Maury S, Huguet E, O'Connor SE, Courdavault V.

Sci Rep. 2017 Jan 17;7:40453. doi: 10.1038/srep40453.

5.

Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy.

Gauthier J, Castagna L, Garnier F, Guillaume T, Socié G, Maury S, Maillard N, Tabrizi R, Marchand T, Malfuson J, Gac A, Gyan E, Mercier M, Béguin Y, Delage J, Turlure P, Marçais A, Nguyen S, Dulery R, Bay J, Huynh A, Daguindau E, Cornillon J, Régny C, Michallet M, Peffault de Latour R, Yakoub-Agha I, Blaise D.

Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.349. [Epub ahead of print]

PMID:
28067872
6.

Immunothérapie et greffe de cellules souches hématopoïétiques allogéniques.

de Fontbrune FS, Cavalieri D, Leclerc M, Beckerich F, Maury S, de Latour RP, N-Guyen S, Bay JO.

Bull Cancer. 2016 Nov;103 Suppl 1:S164-S174. doi: 10.1016/S0007-4551(16)30375-7. French.

PMID:
28057181
7.

Can a reduced-intensity conditioning regimen cure blastic plasmacytoid dendritic cell neoplasm?

Leclerc M, Peffault de Latour R, Michallet M, Blaise D, Chevallier P, Rohrlich PS, Turlure P, Nguyen S, Jardin F, Yakoub-Agha I, Maury S; French Society of Bone Marrow Transplantation and Cell Therapy..

Blood. 2017 Mar 2;129(9):1227-1230. doi: 10.1182/blood-2016-09-726653. Epub 2016 Dec 16. No abstract available.

PMID:
27986653
8.

Isopropanol Dehydration on Amorphous Silica-Alumina: Synergy of Brønsted and Lewis Acidities at Pseudo-Bridging Silanols.

Larmier K, Chizallet C, Maury S, Cadran N, Abboud J, Lamic-Humblot AF, Marceau E, Lauron-Pernot H.

Angew Chem Int Ed Engl. 2017 Jan 2;56(1):230-234. doi: 10.1002/anie.201609494. Epub 2016 Dec 2.

PMID:
27910202
9.

Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia.

Maury S, Chevret S, Thomas X, Heim D, Leguay T, Huguet F, Chevallier P, Hunault M, Boissel N, Escoffre-Barbe M, Hess U, Vey N, Pignon JM, Braun T, Marolleau JP, Cahn JY, Chalandon Y, Lhéritier V, Beldjord K, Béné MC, Ifrah N, Dombret H; for GRAALL..

N Engl J Med. 2016 Sep 15;375(11):1044-53. doi: 10.1056/NEJMoa1605085.

10.

Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells.

Leclerc M, Naserian S, Pilon C, Thiolat A, Martin GH, Pouchy C, Dominique C, Belkacemi Y, Charlotte F, Maury S, Salomon BL, Cohen JL.

Blood. 2016 Sep 22;128(12):1651-9. doi: 10.1182/blood-2016-02-700849. Epub 2016 Aug 9.

PMID:
27506541
11.

Specific T cells for the treatment of cytomegalovirus and/or adenovirus in the context of hematopoietic stem cell transplantation.

Creidy R, Moshous D, Touzot F, Elie C, Neven B, Gabrion A, Leruez-Ville M, Maury S, Ternaux B, Nisoy J, Luby JM, Héritier S, Dalle JH, Ouachée-Chardin M, Xhaard A, Thomas X, Chevallier P, Souchet L, Treluyer JM, Picard C, Hacein-Bey-Abina S, Dal Cortivo L, Blanche S, Cavazzana M.

J Allergy Clin Immunol. 2016 Sep;138(3):920-924.e3. doi: 10.1016/j.jaci.2016.03.032. Epub 2016 Apr 30. No abstract available.

12.

Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working Party.

Devillier R, Dalle JH, Kulasekararaj A, D'aveni M, Clément L, Chybicka A, Vigouroux S, Chevallier P, Koh M, Bertrand Y, Michallet M, Zecca M, Yakoub-Agha I, Cahn JY, Ljungman P, Bernard M, Loiseau P, Dubois V, Maury S, Socié G, Dufour C, Peffault de Latour R.

Haematologica. 2016 Jul;101(7):884-90. doi: 10.3324/haematol.2015.138727. Epub 2016 Apr 7.

13.

Profound lymphopenia is associated with a lower risk of hepatic cytolysis during antithymocyte globulin administration.

Al Dweik B, Redjoul R, Bastuji-Garin S, Beckerich F, Robin C, Pautas C, Toma A, Cabanne L, Maury S, Cordonnier C.

Am J Hematol. 2016 Jun;91(4):E276-8. doi: 10.1002/ajh.24309. No abstract available.

PMID:
26799506
14.

Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study.

Loschi M, Porcher R, Barraco F, Terriou L, Mohty M, de Guibert S, Mahe B, Lemal R, Dumas PY, Etienne G, Jardin F, Royer B, Bordessoule D, Rohrlich PS, Fornecker LM, Salanoubat C, Maury S, Cahn JY, Vincent L, Sene T, Rigaudeau S, Nguyen S, Lepretre AC, Mary JY, Corront B, Socie G, Peffault de Latour R.

Am J Hematol. 2016 Jun;91(4):366-70. doi: 10.1002/ajh.24278.

PMID:
26689746
15.

Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Mamez AC, Lévy V, Chevallier P, Blaise D, Vigouroux S, Xhaard A, Fegueux N, Contentin N, Beguin Y, Ifrah N, Bulabois CE, Suarez F, Yakoub-Agha I, Turlure P, Deconink E, Lamy T, Cahn JY, Huynh A, Maury S, Fornecker LM, Ouzegdouh M, Bay JO, Guillerm G, Maillard N, Michallet M, Malfuson JV, Bourhis JH, Rialland F, Oumedaly R, Jubert C, Leblond V, Boubaya M, Mohty M, Nguyen S.

Bone Marrow Transplant. 2016 Mar;51(3):358-64. doi: 10.1038/bmt.2015.280. Epub 2015 Nov 23.

PMID:
26595076
16.

Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A Report From the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

Ravinet A, Cabrespine A, Socié G, Milpied N, Yakoub Agha I, Nguyen S, Michallet M, Menard AL, Maillard N, Mohty M, Suarez F, Huynh A, Marchand T, Deteix C, Cassuto JP, Maury S, Chevallier P, Reman O, Peffault de Latour R, Bay JO.

Transplantation. 2016 Aug;100(8):1732-9. doi: 10.1097/TP.0000000000000976.

PMID:
26528768
17.

Epigenomics and bolting tolerance in sugar beet genotypes.

Hébrard C, Peterson DG, Willems G, Delaunay A, Jesson B, Lefèbvre M, Barnes S, Maury S.

J Exp Bot. 2016 Jan;67(1):207-25. doi: 10.1093/jxb/erv449. Epub 2015 Oct 13.

18.

Donor Immunization Against Human Leukocyte Class II Antigens is a Risk Factor for Graft-versus-Host Disease.

Delbos F, Barhoumi W, Cabanne L, Beckerich F, Robin C, Redjoul R, Astati S, Toma A, Pautas C, Ansart-Pirenne H, Cordonnier C, Bierling P, Maury S.

Biol Blood Marrow Transplant. 2016 Feb;22(2):292-9. doi: 10.1016/j.bbmt.2015.09.027. Epub 2015 Nov 11.

19.

Allogeneic stem cell transplantation (allo-SCT) for de novo Ph+ AML: a study from the French Society of Bone Marrow Transplantation and Cell Therapy.

Chantepie SP, Michallet M, Blaise D, Maury S, Deconinck E, Tabrizi R, Contentin N, Mohty M, Nguyen S, Lioure B, Raus N, Peffault de Latour R, Yakoub-Agha I, Reman O; SFGM-TC group..

Bone Marrow Transplant. 2015 Dec;50(12):1586-8. doi: 10.1038/bmt.2015.206. Epub 2015 Sep 14. No abstract available.

PMID:
26367219
20.

Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation.

Fioredda F, Iacobelli S, van Biezen A, Gaspar B, Ancliff P, Donadieu J, Aljurf M, Peters C, Calvillo M, Matthes-Martin S, Morreale G, van 't Veer-Tazelaar N, de Wreede L, Al Seraihy A, Yesilipek A, Fischer A, Bierings M, Ozturk G, Smith O, Veys P, Ljungman P, Peffault de Latour R, Sánchez de Toledo Codina J, Or R, Ganser A, Afanasyev B, Wynn R, Kalwak K, Marsh J, Dufour C; Severe Aplastic Anemia the Inborn Error, and the Pediatric Disease Working Parties of the European Society for Blood and Bone Marrow Transplantation (EBMT) and Stem Cell Transplant for Immunodeficiencies in Europe (SCETIDE)..

Blood. 2015 Oct 15;126(16):1885-92; quiz 1970. doi: 10.1182/blood-2015-02-628859. Epub 2015 Jul 16.

Supplemental Content

Loading ...
Support Center